Andrzej Krajewski
Research Subjects
Andrzej Krajewski has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Krzysztof Piorun
West Pomeranian Center of Treating Severe Burns and Plastic Sugery, Niechorska 27 Street, 72-300, Gryfice, Poland
2 shared publications- Maciej Mazurek
West Pomeranian Centre for Severe Burns and Plastic Surgery, Gryfice, Poland
2 shared publications Marta Markowska
Department of Human Nutrition and Metabolomics, Pomeranian Medical University in Szczecin, Szczecin, Poland; West Pomeranian Center of Treating Severe Burns and Plastic Surgery in Gryfice, Gryfice, Poland
2 shared publications- Agnieszka Maruszewska
Institute of Biology, University of Szczecin, Wąska 13, 71-415 Szczecin, Poland
1 shared publication - Agnieszka Surowiecka
Department of Plastic, Reconstructive and Microsurgery, Medical University of Lublin, 20-059 Lublin, Poland
1 shared publication Aldona Stachura
East Center of Burns Treatment and Reconstructive Surgery, Medical University of Lublin , Łęczna , Poland
1 shared publication
Latest Publications
- 1 September 2025
- Published by Evereth Publishing in Forum Leczenia Ran
- Vol. 6 (3) , 85-102
Zastosowanie laserobarii jako wieloskładnikowej terapii wspomagającej leczenie trudno gojących się ran o różnej etiologii – interdyscyplinarne stanowisko ekspertów
Rany trudno gojące się (przewlekłe) stanowią istotny problem kliniczny i społeczny, dotyczący 1,5–2% populacji dorosłych. Szczególne wyzwanie terapeutyczne stanowi cukrzycowa choroba stóp (dawniej: zespół stopy cukrzycowej), odpowiadająca za większość amputacji nieurazowych kończyn dolnych. Współczesne podejście do leczenia ran przewlekłych wymaga terapii zintegrowanej, obejmującej leczenie przyczynowe oraz metody wspomagające proces gojenia. Cel Celem niniejszego dokumentu jest przedstawienie stanowiska eksperckiego dotyczącego wskazań, bezpieczeństwa, organizacji oraz integracji laserobarii w leczeniu ran przewlekłych kończyn dolnych. Materiał i metody Konsensus opracowano na podstawie przeglądu systematycznego literatury z lat 2017–2021 (PubMed, Embase, Cochrane Library), analizy badań klinicznych i metaanaliz dotyczących miejscowej tlenoterapii, ozonoterapii, wolnozmiennego pola elektromagnetycznego oraz fototerapii, a także danych z praktyki klinicznej (RWD) obejmujących ponad 5000 zabiegów wykonanych w polskich ośrodkach. Jakość dowodów oceniono według zmodyfikowanego systemu GRADE. Wyniki Dostępne dane wskazują, że terapia skojarzona, integrująca TOT, ozonoterapię, PEMF oraz światło czerwone i UV w jednej sesji (laserobaria), prowadzi do istotnej redukcji powierzchni ran, przyspieszenia ziarninowania i epitelializacji oraz zmniejszenia dolegliwości bólowych. Najsilniejsze dowody dotyczą leczenia cukrzycowej choroby stóp, gdzie wykazano istotne zmniejszenie ryzyka amputacji oraz zwiększenie odsetka pełnych wygojeń. Terapia cechuje się korzystnym profilem bezpieczeństwa, a działania niepożądane mają charakter łagodny i przemijający. Wnioski Laserobaria może stanowić skuteczną i bezpieczną metodę wspomagającą leczenie ran przewlekłych kończyn dolnych, szczególnie w przypadkach opornych na terapię standardową. Powinna być stosowana w modelu zintegrowanym, zgodnym z koncepcją TIME, w ośrodkach dysponujących odpowiednim zapleczem organizacyjnym i przeszkolonym personelem.
- 1 September 2025
- Published by Evereth Publishing in Forum Leczenia Ran
- Vol. 6 (3) , 85-102
Zastosowanie laserobarii jako wieloskładnikowej terapii wspomagającej leczenie trudno gojących się ran o różnej etiologii – interdyscyplinarne stanowisko ekspertów
Rany trudno gojące się (przewlekłe) stanowią istotny problem kliniczny i społeczny, dotyczący 1,5–2% populacji dorosłych. Szczególne wyzwanie terapeutyczne stanowi cukrzycowa choroba stóp (dawniej: zespół stopy cukrzycowej), odpowiadająca za większość amputacji nieurazowych kończyn dolnych. Współczesne podejście do leczenia ran przewlekłych wymaga terapii zintegrowanej, obejmującej leczenie przyczynowe oraz metody wspomagające proces gojenia. Cel Celem niniejszego dokumentu jest przedstawienie stanowiska eksperckiego dotyczącego wskazań, bezpieczeństwa, organizacji oraz integracji laserobarii w leczeniu ran przewlekłych kończyn dolnych. Materiał i metody Konsensus opracowano na podstawie przeglądu systematycznego literatury z lat 2017–2021 (PubMed, Embase, Cochrane Library), analizy badań klinicznych i metaanaliz dotyczących miejscowej tlenoterapii, ozonoterapii, wolnozmiennego pola elektromagnetycznego oraz fototerapii, a także danych z praktyki klinicznej (RWD) obejmujących ponad 5000 zabiegów wykonanych w polskich ośrodkach. Jakość dowodów oceniono według zmodyfikowanego systemu GRADE. Wyniki Dostępne dane wskazują, że terapia skojarzona, integrująca TOT, ozonoterapię, PEMF oraz światło czerwone i UV w jednej sesji (laserobaria), prowadzi do istotnej redukcji powierzchni ran, przyspieszenia ziarninowania i epitelializacji oraz zmniejszenia dolegliwości bólowych. Najsilniejsze dowody dotyczą leczenia cukrzycowej choroby stóp, gdzie wykazano istotne zmniejszenie ryzyka amputacji oraz zwiększenie odsetka pełnych wygojeń. Terapia cechuje się korzystnym profilem bezpieczeństwa, a działania niepożądane mają charakter łagodny i przemijający. Wnioski Laserobaria może stanowić skuteczną i bezpieczną metodę wspomagającą leczenie ran przewlekłych kończyn dolnych, szczególnie w przypadkach opornych na terapię standardową. Powinna być stosowana w modelu zintegrowanym, zgodnym z koncepcją TIME, w ośrodkach dysponujących odpowiednim zapleczem organizacyjnym i przeszkolonym personelem.
- 9 April 2022
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 43 (6) , 1394-1398
Immunomodulatory Treatment of Lyell’s Syndrome: A Simultaneous Plasmapheresis and Intravenous Immunoglobulins Therapy
Lyell’s syndrome, or toxic epidermal necrolysis (TEN) is a rare but life-threatening condition. It manifests with blistering of skin and mucous due to subepidermal bullae and keratinocyte necrosis. In most cases, it is an immune response to drugs or their metabolites. The mortality in TEN is high despite optimal infection and wound control. There are no unequivocal treatment guidelines in TEN. Immunosuppressive treatment may increase the wound infection risk and mortality. The aim of the study was to evaluate a 10-year experience with immunomodulatory therapy in TEN. We perform a combination of plasmapheresis and intravenous immunoglobulins to control the disease. There were 35 patients in the group and we performed a post hoc evaluation. Twenty-eight patients received the full protocol and there were seven patients who did not complete the treatment (single therapy group). The mortality in the test group was 14.29%, and the difference reached statistical significance in comparison with the single therapy group (P < .05). Our protocol reduced the mortality risk five times. Our study proved that simultaneous plasmaphereses with intravenous immunoglobulins administration were safe and improved patients’ outcome in TEN.
- 9 April 2022
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 43 (6) , 1394-1398
Immunomodulatory Treatment of Lyell’s Syndrome: A Simultaneous Plasmapheresis and Intravenous Immunoglobulins Therapy
Lyell’s syndrome, or toxic epidermal necrolysis (TEN) is a rare but life-threatening condition. It manifests with blistering of skin and mucous due to subepidermal bullae and keratinocyte necrosis. In most cases, it is an immune response to drugs or their metabolites. The mortality in TEN is high despite optimal infection and wound control. There are no unequivocal treatment guidelines in TEN. Immunosuppressive treatment may increase the wound infection risk and mortality. The aim of the study was to evaluate a 10-year experience with immunomodulatory therapy in TEN. We perform a combination of plasmapheresis and intravenous immunoglobulins to control the disease. There were 35 patients in the group and we performed a post hoc evaluation. Twenty-eight patients received the full protocol and there were seven patients who did not complete the treatment (single therapy group). The mortality in the test group was 14.29%, and the difference reached statistical significance in comparison with the single therapy group (P < .05). Our protocol reduced the mortality risk five times. Our study proved that simultaneous plasmaphereses with intravenous immunoglobulins administration were safe and improved patients’ outcome in TEN.
- 19 April 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (4) , e13442
Successful therapy of recurrent toxic epidermal necrolysis using total plasma exchange, continuous venovenous hemodiafiltration, and intravenous immunoglobulin—Case report
- 19 April 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (4) , e13442
Successful therapy of recurrent toxic epidermal necrolysis using total plasma exchange, continuous venovenous hemodiafiltration, and intravenous immunoglobulin—Case report
- 29 April 2019
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 40 (5) , 652-657
Toxic Epidermal Necrolysis Therapy with TPE and IVIG—10 Years of Experience of the Burns Treatment Center
Toxic epidermal necrolysis (TEN) is a potentially life-threatening, exfoliative disease. It is described as idiosyncratic, severe, skin reaction to drugs. With Stevens–Johnson’s Syndrome, it presents as a continuum of a disease being categorized relating to the percentage of affected skin. Without any multicenter trials comparing TEN treatment modalities, there is dearth of strong evidence-based guidelines of care. Total plasma exchange with intravenous immunoglobulin (IVIG) is one among plethora of possible treatment strategies. In our 10-year experience, we have observed 21 patients admitted to our burns center due to TEN. All of them were placed under intensive care with daily plasmapheresis (TPE) and IVIG. We have observed 52% mortality, with observed severe concomitant diseases in every patient in nonsurvivor group (average Acute Physiology and Chronic Health Evaluation II score at admission: 31.5%). We consider that TPE with IVIG might be of use in selected group of patients with TEN without any severe comorbidities. However, further multicenter trials are needed because in some cases it may raise mortality.
- 29 April 2019
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 40 (5) , 652-657
Toxic Epidermal Necrolysis Therapy with TPE and IVIG—10 Years of Experience of the Burns Treatment Center
Toxic epidermal necrolysis (TEN) is a potentially life-threatening, exfoliative disease. It is described as idiosyncratic, severe, skin reaction to drugs. With Stevens–Johnson’s Syndrome, it presents as a continuum of a disease being categorized relating to the percentage of affected skin. Without any multicenter trials comparing TEN treatment modalities, there is dearth of strong evidence-based guidelines of care. Total plasma exchange with intravenous immunoglobulin (IVIG) is one among plethora of possible treatment strategies. In our 10-year experience, we have observed 21 patients admitted to our burns center due to TEN. All of them were placed under intensive care with daily plasmapheresis (TPE) and IVIG. We have observed 52% mortality, with observed severe concomitant diseases in every patient in nonsurvivor group (average Acute Physiology and Chronic Health Evaluation II score at admission: 31.5%). We consider that TPE with IVIG might be of use in selected group of patients with TEN without any severe comorbidities. However, further multicenter trials are needed because in some cases it may raise mortality.
- 1 January 2019
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 45 (1) , 82-84
Severe Post-Traumatic Hypothermia in a Burned Patient
- 1 January 2019
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 45 (1) , 82-84
Severe Post-Traumatic Hypothermia in a Burned Patient
- 1 September 2014
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 35 (5) , e294-e303
Active Dynamic Infrared Thermal Imaging in Burn Depth Evaluation
The aim of this study was to find the relationship between active dynamic thermography (ADT) with cold excitation and burn depth. This new modality of evaluation of burns seems to be an attractive proposal for quantitative classification, allowing proper choice of burn wound treatment: conservative or surgical, especially compared with static thermography. The work was an in vivo experiment on domestic pigs, and a small number of patients were also diagnosed as part of the study. Statistical analysis showed a high correlation between the ADT synthetic parameter—thermal time constant, τ—and the classification of burn wounds that were predicted to heal within 3 weeks and so were treated conservatively and those that were predicted to not heal within 3 weeks and so were surgically treated. The results of the study show an accuracy of 60.7% for clinical evaluation, 69.6% for static thermography, 83.0% for ADT, and 84.0% for histopathologic assessment. The authors have concluded that the ADT method with cold excitation is suitable for the qualitative and quantitative assessment of burn depth.
- 1 September 2014
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 35 (5) , e294-e303
Active Dynamic Infrared Thermal Imaging in Burn Depth Evaluation
The aim of this study was to find the relationship between active dynamic thermography (ADT) with cold excitation and burn depth. This new modality of evaluation of burns seems to be an attractive proposal for quantitative classification, allowing proper choice of burn wound treatment: conservative or surgical, especially compared with static thermography. The work was an in vivo experiment on domestic pigs, and a small number of patients were also diagnosed as part of the study. Statistical analysis showed a high correlation between the ADT synthetic parameter—thermal time constant, τ—and the classification of burn wounds that were predicted to heal within 3 weeks and so were treated conservatively and those that were predicted to not heal within 3 weeks and so were surgically treated. The results of the study show an accuracy of 60.7% for clinical evaluation, 69.6% for static thermography, 83.0% for ADT, and 84.0% for histopathologic assessment. The authors have concluded that the ADT method with cold excitation is suitable for the qualitative and quantitative assessment of burn depth.
- 15 May 2011
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 8 (1) , 184-194
Stem Cells, Including a Population of Very Small Embryonic-Like Stem Cells, are Mobilized Into Peripheral Blood in Patients After Skin Burn Injury
Background Developmentally early cells, including hematopoietic stem progenitor cells (HSPCs), as well as very small embryonic-like stem cells (VSELs), are mobilized into peripheral blood (PB) in response to tissue and organ injury (e.g., heart infarct or stroke). Objective We seek to determine whether these cells are also mobilized into PB in patients with skin burn injuries. Methods Forty-four (44) patients (33–57 years of age) with total body surface burn area of 30–60%, as well as 23 healthy control subjects, were recruited and PB samples were harvested during the first 24 hours, day +2, and day +5 after burn injury and compared to normal controls. The circulating human CD34+CD133+ cells enriched for HSPCs, as well as small CXCR4+CD34+CD133+ subsets of Lin–CD45– cells that correspond to the population of VSELs, were counted by FACS and evaluated by direct immunofluorescence staining for pluripotency markers (Oct-4, Nanog, and SSEA-4). In parallel, we also measured by ELISA the serum concentration of factors that regulate stem cell trafficking, such as SDF-1, VEGF, and HGF. Results Our data indicate that skin burn injury mobilizes cells expressing stem cell-associated markers, such as CD133, CD34, and CXCR4, into PB. More importantly, we found an increase in the number of circulating primitive, small Oct-4+Nanog+SSEA-4+CXCR4+lin–CD45– VSELs. All these changes were accompanied by increased serum concentrations of SDF-1 and VEGF. Limitations Further studies are needed to fully assess the role of mobilized stem cells in the healing process to see if they can contribute to skin regeneration. Conclusion Skin burn injury triggers the mobilization of HSPCs and CXCR4+ VSELs, while the significance and precise role of mobilized VSELs in skin repair requires further study.
- 15 May 2011
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 8 (1) , 184-194
Stem Cells, Including a Population of Very Small Embryonic-Like Stem Cells, are Mobilized Into Peripheral Blood in Patients After Skin Burn Injury
Background Developmentally early cells, including hematopoietic stem progenitor cells (HSPCs), as well as very small embryonic-like stem cells (VSELs), are mobilized into peripheral blood (PB) in response to tissue and organ injury (e.g., heart infarct or stroke). Objective We seek to determine whether these cells are also mobilized into PB in patients with skin burn injuries. Methods Forty-four (44) patients (33–57 years of age) with total body surface burn area of 30–60%, as well as 23 healthy control subjects, were recruited and PB samples were harvested during the first 24 hours, day +2, and day +5 after burn injury and compared to normal controls. The circulating human CD34+CD133+ cells enriched for HSPCs, as well as small CXCR4+CD34+CD133+ subsets of Lin–CD45– cells that correspond to the population of VSELs, were counted by FACS and evaluated by direct immunofluorescence staining for pluripotency markers (Oct-4, Nanog, and SSEA-4). In parallel, we also measured by ELISA the serum concentration of factors that regulate stem cell trafficking, such as SDF-1, VEGF, and HGF. Results Our data indicate that skin burn injury mobilizes cells expressing stem cell-associated markers, such as CD133, CD34, and CXCR4, into PB. More importantly, we found an increase in the number of circulating primitive, small Oct-4+Nanog+SSEA-4+CXCR4+lin–CD45– VSELs. All these changes were accompanied by increased serum concentrations of SDF-1 and VEGF. Limitations Further studies are needed to fully assess the role of mobilized stem cells in the healing process to see if they can contribute to skin regeneration. Conclusion Skin burn injury triggers the mobilization of HSPCs and CXCR4+ VSELs, while the significance and precise role of mobilized VSELs in skin repair requires further study.